Multicentre, randomised, open-label, non-inferiority trial comparing the effectiveness and safety of ductal lavage versus oral corticosteroids for idiopathic granulomatous mastitis: a study protocol

Tingting Hu, Shunrong Li, Heng Huang, Hui Huang, Luyuan Tan, Yanbo Chen, Heran Deng, Jiannan Wu, Liling Zhu, Jian Zhang, Fengxi Su, Kai Chen, Tingting Hu, Shunrong Li, Heng Huang, Hui Huang, Luyuan Tan, Yanbo Chen, Heran Deng, Jiannan Wu, Liling Zhu, Jian Zhang, Fengxi Su, Kai Chen

Abstract

Introduction: The ideal treatment for idiopathic granulomatous mastitis (IGM) remains unclear. In a prospective, single-centre, pilot study, we reported that ductal lavage treatment for non-lactational mastitis patients had a 1-year clinical complete response (cCR) rate of >90%, without any significant adverse events. Thus, in this multicentre, randomised, open-label, non-inferiority trial, we will aim to compare the effectiveness and safety of ductal lavage vs oral corticosteroids as the first-line treatment for patients with IGM.

Methods and analysis: The trial will be conducted at the Breast Tumor Center of Sun Yat-sen Memorial Hospital in China and at least at one participating regional centre. We plan to recruit 140 eligible IGM patients who will be randomised into the ductal lavage group or oral corticosteroid group with a 1:1 ratio. The patients in the oral corticosteroid group will receive meprednisone or prednisone for 6 months. The patients in the ductal lavage group will receive ductal lavage and breast massage, as previously reported. All the participants will be followed up at the clinic for 1 year post randomisation. The primary endpoint of this trial will be the 1-year cCR rate, and the secondary endpoints will include the time to cCR, treatment failure rate, relapse rate and protocol compliance rate. The trial was designed to determine whether ductal lavage is non-inferior to oral corticosteroids (1-year cCR rate assumed to be 90%), with a non-inferiority margin of 15%.

Ethics and dissemination: The ethics committee of Sun Yat-sen Memorial Hospital at Sun Yat-sen University approved the study (2018-Lun-Shen-Yan-No. 30). The results of the trial will be communicated to the participating primary care practices, published in international journals and presented at international clinical and scientific conferences.

Trial registration number: ClinicalTrials.gov Registry (NCT03724903); Pre-results.

Keywords: breast surgery; breast tumours; histology.

Conflict of interest statement

Competing interests: None declared.

© Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

References

    1. Chen K, Zhu L, Hu T, et al. . Ductal lavage for patients with Nonlactational mastitis: a single-arm, proof-of-concept trial. J Surg Res 2019;235:440–6. 10.1016/j.jss.2018.10.023
    1. Karanlik H, Ozgur I, Simsek S, et al. . Can steroids plus surgery become a first-line treatment of idiopathic granulomatous mastitis? Breast Care 2014;9:338–42. 10.1159/000366437
    1. Yabanoğlu H, Çolakoğlu T, Belli S, et al. . A comparative study of conservative versus surgical treatment protocols for 77 patients with idiopathic granulomatous mastitis. Breast J 2015;21:363–9. 10.1111/tbj.12415
    1. Erozgen F, Ersoy YE, Akaydin M, et al. . Corticosteroid treatment and timing of surgery in idiopathic granulomatous mastitis confusing with breast carcinoma. Breast Cancer Res Treat 2010;123:447–52. 10.1007/s10549-010-1041-6
    1. Akbulut S, Arikanoglu Z, Senol A, et al. . Is methotrexate an acceptable treatment in the management of idiopathic granulomatous mastitis? Arch Gynecol Obstet 2011;284:1189–95. 10.1007/s00404-010-1825-2
    1. Akbulut S, Yilmaz D, Bakir S. Methotrexate in the management of idiopathic granulomatous mastitis: review of 108 published cases and report of four cases. Breast J 2011;17:661–8. 10.1111/j.1524-4741.2011.01162.x
    1. Bouton ME, Jayaram L, O'Neill PJ, et al. . Management of idiopathic granulomatous mastitis with observation. Am J Surg 2015;210:258–62. 10.1016/j.amjsurg.2014.08.044
    1. CNKI . Experts consensus of nonlactational mastitis, 2016. Available:
    1. Chan A-W, Tetzlaff JM, Altman DG, et al. . SPIRIT 2013 statement: defining standard protocol items for clinical trials. Ann Intern Med 2013;158:200–7. 10.7326/0003-4819-158-3-201302050-00583
    1. Han S, Hong YG. The inverted nipple: its grading and surgical correction. Plast Reconstr Surg 1999;104:389–95. 10.1097/00006534-199908000-00010
    1. Harris PA, Taylor R, Thielke R, et al. . Research electronic data capture (REDCap)--a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform 2009;42:377–81. 10.1016/j.jbi.2008.08.010
    1. Aghajanzadeh M, Hassanzadeh R, Alizadeh Sefat S, et al. . Granulomatous mastitis: presentations, diagnosis, treatment and outcome in 206 patients from the North of Iran. Breast 2015;24:456–60. 10.1016/j.breast.2015.04.003
    1. Hur SM, Cho DH, Lee SK, et al. . Experience of treatment of patients with granulomatous lobular mastitis. J Korean Surg Soc 2013;85:1–6. 10.4174/jkss.2013.85.1.1
    1. Lei X, Chen K, Zhu L, et al. . Treatments for idiopathic granulomatous mastitis: systematic review and meta-analysis. Breastfeed Med 2017;12:415–21. 10.1089/bfm.2017.0030
    1. Al-Khaffaf B, Knox F, Bundred NJ. Idiopathic granulomatous mastitis: a 25-year experience. J Am Coll Surg 2008;206:269–73. 10.1016/j.jamcollsurg.2007.07.041
    1. Sakurai K, Fujisaki S, Enomoto K, et al. . Evaluation of follow-up strategies for corticosteroid therapy of idiopathic granulomatous mastitis. Surg Today 2011;41:333–7. 10.1007/s00595-009-4292-2
    1. Yau FM, Macadam SA, Kuusk U, et al. . The surgical management of granulomatous mastitis. Ann Plast Surg 2010;64:9–16. 10.1097/SAP.0b013e3181a20cae
    1. Dooley WC, Ljung BM, Veronesi U, et al. . Ductal lavage for detection of cellular atypia in women at high risk for breast cancer. J Natl Cancer Inst 2001;93:1624–32. 10.1093/jnci/93.21.1624
    1. Evron E, Dooley WC, Umbricht CB, et al. . Detection of breast cancer cells in ductal lavage fluid by methylation-specific PCR. Lancet 2001;357:1335–6. 10.1016/S0140-6736(00)04501-3
    1. Stearns V, Mori T, Jacobs LK, et al. . Preclinical and clinical evaluation of intraductally administered agents in early breast cancer. Sci Transl Med 2011;3:106ra108. 10.1126/scitranslmed.3002368
    1. Courtney M, Townsend Jr RDB, Mark Evers B, et al. . Sabiston textbook of surgery:the biological basis of modern surgical practice. Philadelphia: Saunders, 2007.
    1. MTaM H. Atlas of ultrasound and ductal echography of the breast: the introduction of anatomic intelligence into breast imaging. 1 edn. Hoboken, New Jersey: Wiley-Blackwell, 1995.
    1. Flanagan M, Love S, Hwang ES. Status of intraductal therapy for ductal carcinoma in situ. Curr Breast Cancer Rep 2010;2:75–82. 10.1007/s12609-010-0015-3
    1. Sartorius OW, Smith HS, Morris P, et al. . Cytologic evaluation of breast fluid in the detection of breast disease. J Natl Cancer Inst 1977;59:1073–80. 10.1093/jnci/59.4.1073
    1. Vinay Kumar AKA, Aster. Robbins JC. Cotran pathologic basis of disease. Amsterdam, Netherlands: Elsevier, 2014.
    1. Susan C, Lester DGH. Diagnostic pathology: breast. 2 edn. Elsevier, 2016.

Source: PubMed

Sponsorzy i współpracownicy

Warunki medyczne

Interwencje lekowe

3
Subskrybuj